Greece Battles Candida Auris Outbreak, Second in EU
Greece is grappling with a significant rise in Candida auris cases, a dangerous fungus that poses a severe threat to seriously ill patients. The country has recorded 852 cases in the last decade, ranking second in the EU for such infections.
Candida auris is now prevalent in Greek hospitals, spreading throughout the healthcare system. It often affects severely ill patients, preventing them from recovering from their hospitalising illness. The fungus is also known for its resistance to antifungal drugs, making it difficult to treat.
To combat this, Greek health officials support mandatory reporting of Candida auris cases. Early detection and rapid, coordinated control are crucial to prevent further spread. However, information on the current head of the Antimicrobial Resistance and Hospital Infections Department of the National Health Administration in Greece, or about Lida Politi, is not readily available.
Candida auris is a serious concern in Greek hospitals, with 852 cases recorded in the last decade. Its resistance to drugs and impact on severely ill patients make it a significant threat. Mandatory reporting is encouraged to control its spread, and early detection is vital for patient safety.
